Below you can fin all our press releases and company info
- Latest News
- Oldest News
- Year 2023
- Year 2022
- Year 2021
- Year 2020
- Year 2019
- Year 2018
- Year 2017
- Year 2016
- Year 2015
- Year 2014
EryDel Provides Regulatory Update on EryDex for the Treatment of Ataxia ...
February 22, 2023Read more
EryDel to Present its Phase 3 Study Results for Ataxia Telangiectasia ...
April 05, 2022Read more
EryDel’s Luca Benatti Discusses Red Blood Cell Infusion Biotech for Ataxia ...
March 08, 2022Read more
Bedside Red Blood Cell Encapsulation Delivering Drugs for Rare ...
March 07, 2022Read more
Rare Disease Day
February 28, 2022Read more
EryDel Appoints Thomas Sabia as Chief Commercial Officer
February 22, 2022Read more
EryDel Announces Top-line Results from Phase 3 ATTeST Trial Demonstrating Significant ...
July 12, 2021Read more
Taking part in the First International Campaign Raising Awareness for Ataxia ...
December 04, 2020Read more
EryDel Appoints Dr Esin Kosal, PhD,as Senior Vice President, Global Regulatory ...
November 30, 2020Read more
EryDel Appoints Carlo Incerti, MD, as Chairman of its Board of ...
November 20, 2020Read more
International Ataxia Awareness Day (IAAD)
September 25, 2020Read more
EU support for Italian biotech’s red blood cell technology to treat ...
August 06, 2020Read more
EryDel Announces Completion of Patient Enrollment in Phase 3 ATTeST Trial ...
April 14, 2020Read more
Rare Disease Day
February 29, 2020Read more
20th ANNUAL INTERNATIONAL ATAXIA AWARENESS DAY
September 25, 2019Read more
EryDel to present at
Italian A-T Association Family Weekend
September 18, 2019Read more
EryDel to Present at A-T
Society Family Weekend
July 20, 2019Read more
Luca Benatti, President and Chief Executive Officer, and Stan Musial, Chief ...
June 10, 2019Read more
EryDel Appoints Alyssa Wyant as Senior Vice President, Regulatory Affairs.
January 08, 2019Read more
EryDel Appoints Stan Musial as Chief Financial Officer
November 12, 2018Read more
EryDel appoints Ronan Gannon as Chief Commericial Officer
October 15, 2018Read more
EryDel-Orphan Technologies signing a licensing and supply agreement
June 04, 2018Read more
EryDel to present at the UBS Global Healthcare Conference 2018
May 14, 2018Read more
EryDel Raises Euro 26.5 Million in Financing
April 24, 2018Read more
EryDel Appoints Guenter R Janhofer, MD, as Chief Medical Officer
February 16, 2018Read more
EryDel announced the initiation of the Ataxia Telangiectasia Trial with the ...
March 06, 2017Read more
EryDel Consortium gains Euro 6 million Funding for development of EDS ...
January 07, 2016Read more
Long term benefit of erytrocyte-delivered dexamathasone in Ataxia Telangiectasia
May 19, 2015Read more
EryDel expands Series B financing to 29.5M
May 11, 2015Read more
Phase II results in Ataxia Telangiectasia published in Orphanet Journal of ...
February 20, 2014Read more